Article
CpG island methylator phenotype in plasma is associated with hepatocellular carcinoma prognosis.
World journal of gastroenterology - 14 Nov 2011
Liu Ji-Bin, Zhang Yi-Xin, Zhou Shu-Hui, Shi Min-Xin, Cai Jin, Liu Yan, Chen Ke-Ping, Qiang Fu-Lin
Abstract excerpt
AIM: To evaluate the clinical significance of CpG island methylator phenotype (CIMP) in plasma and its association with hepatocellular carcinoma (HCC) progress. METHODS: CIMP status of 108 HCC patients was analyzed using a methylation marker panel in tumor tissues and plasma with methylation-specific polymerase chain reaction. Fifteen samples of non-neoplastic liver tissues and 60 of plasma from healthy persons...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
